The Journal of Organic Chemistry
Article
Dilute aqueous sodium thiosulphate solution was added and stirred
well. The organic layer was collected, washed with deionized water,
and dried over anhydrous magnesium sulfate. Solvent was removed
from the filtrate, and column chromatography was performed using
gradient elution from pure hexane to hexane/DCM mixture (15%
DCM for 7a, 7c and 7d, 20% DCM for 7b, 7e and 7f, and 30% DCM
for 7g).
29.77, 29.98, 30.04, 30.7, 31.5, 32.0, 38.1, 39.2, 51.6, 61.2, 102.3, 113.2,
114.0, 116.0, 129.7, 129.9, 130.0, 130.4, 133.1, 136.2, 138.2, 138.3,
141.5, 143.3, 149.3. Anal. Calcd for C63H102Br2N5S2: C, 65.54; H, 8.99;
Br, 13.84; N, 6.07; S, 5.55. Found: C, 65.47; H, 9.01; N, 6.16; S, 5.49.
MALDI-TOF-MS m/z: 1153.49 (M+); calcd for C63H102Br2N5S2 =
1154.46.
General Procedures for Suzuki Polymerization. A 0.4 g
portion of the dibromo annelated benzotriazole monomer, 1 equiv of
fluorene diboronic acid pinacol ester, and 8 mol % Pd[PPh3]4 in 20
mL of toluene and 20 mL of 2 M K2CO3 was added into a round-
bottom flask purged with N2. The reaction was allowed to stirred at 80
°C for 2 days. The reaction mixture was extracted using dichloro-
methane and deionized water, and the organic layer was collected and
dried over anhydrous magnesium sulfate. The collected filtrate was
concentrated and precipitated in methanol twice.
1
7a: 85% yield. H NMR (CDCl3): δ [ppm] 0.89 (m, 12 H), 1.25−
1.44 (m, 80 H), 2.31 (m, 2 H), 4.75 (d, 4 H, J = 6.0), 7.19 (d, 2H, J =
4.0 Hz), 8.35 (br, 2 H). 13C NMR (CDCl3): δ [ppm] 14.3, 22.9, 26.5,
29.5, 29.8, 29.9, 30.1, 31.7, 32.1, 39.4, 60.7, 108.9, 116.2, 129.8, 130.5,
139.0, 140.6. Anal. Calcd for C62H102Br2N6S2: C, 64.45; H, 8.90; Br,
13.83; N, 7.27; S, 5.55. Found: C, 64.37; H, 8.99; N, 7.36; S, 5.42.
MALDI-TOF-MS m/z: 1152.24 (M+); calcd for C62H102Br2N6S2 =
1155.45.
1
7b: 91% yield. 1H NMR (CDCl3): δ [ppm] 0.88 (m, 12 H), 1.08−
1.38 (m, 80 H), 1.57 (m, 1 H), 2.31 (m, 1 H), 4.53 (d, 2 H, J = 7.6
Hz), 4.75 (d, 2 H, J = 6.4), 7.01 (d, 1 H, J = 3.6 Hz), 7.20−7.23 (m, 2
H), 8.69 (d, 1 H, J = 4.4 Hz). 13C NMR (CDCl3): δ [ppm] 14.3,
22.79, 22.84, 26.0, 26.3, 29.48, 29.51, 29.6, 29.75, 29.76, 29.79, 29.81,
30.0, 30.1, 30.9, 31.6, 32.1, 38.5, 39.3, 54.4, 61.0, 100.5, 114.2, 114.7,
118.2, 130.0, 130.3, 130.7, 131.2, 132.3, 135.4, 137.3, 138.6, 142.5,
145.3. Anal. Calcd for C62H102Br2N6S2: C, 64.45; H, 8.90; Br, 13.83; N,
7.27; S, 5.55. Found: C, 64.33; H, 9.01; N, 7.33; S, 5.43. MALDI-TOF-
MS m/z: 1154.03 (M+); calcd for C62H102Br2N6S2 = 1155.45.
P1: H NMR (CDCl3): δ [ppm] 0.80−0.86 (br, -CH3), 1.13−1.63
(br, -CH2), 2.11 (br, fluorene-CH2), 2.48 (br, -CH), 4.96 (br, N-CH2),
7.47−7.80 (br, Ar-H), 8.77 (br, Th-H). Anal. Calcd for
(C91H144N6S2)n: C, 78.84; H, 10.47; N, 6.06; S, 4.63. Found: C,
78.47; H, 10.40; N, 6.16; S, 4.62.
1
P2: H NMR (CDCl3): δ [ppm] 0.80−0.87 (br, -CH3), 1.07−1.39
(br, -CH2), 1.73 (br, -CH), 2.09 (fluorene-CH2), 2.42 (br, -CH), 4.70
(br, N-CH2), 4.84 (br, N-CH2), 7.51−7.85 (br, Ar-H), 9.00 (br, Th-
H). Anal. Calcd for (C91H144N6S2)n: C, 78.84; H, 10.47; N, 6.06; S,
4.63. Found: C, 78.45; H, 10.41; N, 6.20; S, 4.66.
1
1
P3: H NMR (CDCl3): δ [ppm] 0.79 (br, -CH3), 0.87 (br, -CH3),
7c: 82% yield. H NMR (CDCl3): δ [ppm] 0.88 (m, 6 H), 1.23−
1.10−1.46 (br, -CH2), 2.09 (br, fluorene-CH2), 2.43 (br, -CH), 4.89
(br, N-CH2), 7.12−7.77 (br, Ar-H), 8.58 (br, Ar-H), 8.88 (br, Th-H).
Anal. Calcd for (C67H95N5S3)n: C, 75.44; H, 8.98; N, 6.57; S, 9.02.
Found: C, 75.27; H, 8.99; N, 6.61; S, 8.81.
1.40 (m, 40 H), 2.27 (m, 1 H), 4.66 (d, 2 H, J = 6.4), 7.10 (d, 2H, J =
4.0 Hz), 8.26 (d, 2 H, J = 3.2 Hz). 13C NMR (CDCl3): δ [ppm] 14.3,
22.9, 26.4, 29.5, 29.8, 29.9, 30.1, 31.7, 32.1, 39.4, 61.2, 110.8, 117.8,
130.5, 131.1, 138.7, 141.8, 149.0. Anal. Calcd for C38H53Br2N5S3: C,
54.60; H, 6.39; Br, 19.12; N, 8.38; S, 11.51. Found: C, 54.49; H, 6.45;
N, 8.43; S, 11.53. MALDI-TOF-MS m/z: 836.83 (M+); calcd for
C38H53Br2N5S3 = 835.86.
1
P4: H NMR (CDCl3): δ [ppm] 0.79 (br, -CH3), 0.87(br, -CH3),
1.09−1.39 (br, -CH2), 2.07 (br, fluorene-CH2), 2.42 (br, -CH), 4.84
(br, N-CH2), 7.12−7.74 (br, Ar-H), 8.58 (br, Ar-H), 8.88 (br, Th-H).
Anal. Calcd for (C67H95N5S2Se)n: C, 72.26; H, 8.60; N, 6.29; S, 5.76;
Se, 7.09. Found: C, 72.02; H, 8.52; N, 6.38; S, 5.55.
1
7d: 88% yield. H NMR (CDCl3): δ [ppm] 0.88 (m, 6 H), 1.23−
1.38 (m, 40 H), 2.24 (m, 1 H), 4.58 (d, 2 H, J = 6.4), 7.09 (d, 2H, J =
4.0 Hz), 8.23 (d, 2 H, J = 3.6 Hz). 13C NMR (CDCl3): δ [ppm] 14.3,
22.8, 26.4, 29.5, 29.8, 29.9, 30.1, 31.6, 32.1, 39.3, 61.3, 110.9, 118.5,
130.3, 131.2, 139.3, 142.4, 154.9. Anal. Calcd for C38H53Br2N5S2Se: C,
51.70; H, 6.05; Br, 18.10; N, 7.93; S, 7.26; Se, 8.94. Found: C, 51.55;
H, 6.16; N, 8.03; S, 7.33. MALDI-TOF-MS m/z: 884.77 (M+); calcd
for C38H53Br2N5S2Se = 882.76.
1
P5: H NMR (CDCl3): δ [ppm] 0.74 (br, -CH3), 0.86 (br, -CH3),
1.00−1.42 (br, -CH2), 1.81 (br, OCH2-CH2), 2.03(br, fluorene-CH2),
2.37 (br, -CH), 4.02 (br, O-CH2), 4.83 (br, N-CH2), 7.00−8.00 (br,
Ar-H), 8.74 (br, Ar-H), 9.00 (br, Th-H). Anal. Calcd for
(C101H129N5O2S2)n: C, 80.38; H, 8.62; N, 4.64; O, 2.12; S, 4.25.
Found: C, 80.09; H, 8.51; N, 4.74; S, 4.18.
1
7e: 95% yield. 1H NMR (CDCl3): δ [ppm] 0.90 (m, 6 H), 1.04 (t, 6
H, 7.2 Hz), 1.23−1.30 (m, 40 H), 1.56 (sextet, 4 H, J = 7.2 Hz), 1.84
(quintet, 4 H, J = 6.8 Hz), 2.19 (m, 1 H), 4.04 (t, 4 H, J = 6.4 Hz),
4.54 (d, 2 H, J = 7.0), 7.01 (d, 4 H, J = 8.4 Hz), 7.13 (d, 2H, J = 4.0
Hz), 7.64 (m, 8 H), 7.76, (d, 4 H, J = 8.0 Hz), 8.51 (d, 2 H, J = 4.4
Hz). 13C NMR (CDCl3): δ [ppm] 14.1, 14.3, 19.4, 22.9, 26.3, 29.5,
29.77, 29.81, 29.83, 29.86, 30.1, 31.5, 31.6, 32.1, 39.2, 60.6, 67.9, 115.0,
118.3, 119.5, 126.2, 128.3, 129.4, 131.6, 131.8, 132.5, 132.6, 136.3,
137.3, 141.2, 141.5, 151.6, 159.2. Anal. Calcd for C72H87Br2N5O2S2: C,
67.64; H, 6.86; Br, 12.50; N, 5.48; O, 2.50; S, 5.02. Found: C, 67.53;
H, 6.91; N, 5.50; S, 5.20. MALDI-TOF-MS m/z: 1279.70 (M+); calcd
for C72H87Br2N5O2S2 = 1278.43.
P6: H NMR (CDCl3): δ [ppm] 0.79−0.92 (br, -CH3), 1.09−1.34
(br, -CH2), 1.72 (br, ArCH2-CH2), 2.02 (br, fluorene-CH2), 2.29 (br,
-CH), 2.83 (Th-CH2), 4.75 (br, N-CH2), 6.75−7.94 (br, Ar-H), 8.58
(br, Ar-H), 8.90 (br, Th-H). Anal. Calcd for (C97H129N5S6)n: C, 74.80;
H, 8.35; N, 4.50; S, 12.35. Found: C, 74.67; H, 8.30; N, 4.61; S, 12.18.
1
P7: H NMR (CDCl3): δ [ppm] 0.79−0.88 (br, -CH3), 1.09−1.24
(br, -CH2), 1.63 (br, -CH), 2.04 (fluorene-CH2), 2.31 (br, -CH), 4.00
(br, N-CH2), 4.72 (br, N-CH2), 6.97−8.08 (br, Ar-H), 8.56 (br, Ar-
H), 8.84 (br, Th-H). Anal. Calcd for (C92H145N5S2)n: C, 79.77; H,
10.55; N, 5.06; S, 4.63. Found: C, 79.67; H, 10.49; N, 5.19; S, 4.47.
ASSOCIATED CONTENT
■
7f: 93% yield. 1H NMR (CDCl3): δ [ppm] 0.90 (t, 6 H, J = 6.8 Hz),
0.95 (t, 6 H, 6.4 Hz), 1.22−1.45 (m, 52 H), 1.75 (quintet, 4 H, J = 7.6
Hz), 2.17 (m, 1 H), 2.86 (t, 4 H, J = 7.6 Hz), 4.57 (d, 2 H, J = 6.4 Hz),
6.76 (d, 2 H, J = 3.2 Hz), 7.01 (d, 2 H, J = 4.0 Hz), 7.04 (d, 2 H, J =
4.4 Hz), 7.19 (d, 2H, J = 3.6 Hz), 7.41 (d, 2 H, J = 4.0 Hz), 8.38 (d, 2
H, J = 3.6 Hz). 13C NMR (CDCl3): δ [ppm] 14.28, 14.30, 22.8, 22.9,
26.3, 29.0, 29.6, 29.82, 29.85, 29.89, 30.1, 30.4, 31.6, 31.7, 31.8, 32.1,
39.2, 60.5, 117.7, 119.2, 123.0, 124.7, 125.3, 129.2, 131.7, 131.9, 132.1,
134.7, 137.1, 139.4, 141.3, 142.8, 144.1, 146.7. Anal. Calcd for
C68H87Br2N5S6: C, 61.56; H, 6.61; Br, 12.05; N, 5.28; S, 14.50. Found:
C, 61.44; H, 6.73; N, 5.64; S, 14.55. MALDI-TOF-MS m/z: 1327.58
(M+); calcd for C68H87Br2N5S6 = 1326.65.
S
* Supporting Information
NMR and MALDI-TOF spectra of 6c−6g, CF3-ImBTa, 7a−
7g, and P1−P7; CV plots for P1−P7. This material is available
AUTHOR INFORMATION
■
Corresponding Author
Notes
7g: 95% yield. 1H NMR (CDCl3): δ [ppm] 0.90 (m, 12 H), 1.09−
1.36 (m, 81 H), 2.28 (m, 1 H), 3.93 (d, 2 H, J = 7.2 Hz), 4.69 (d, 2 H,
J = 6.4), 6.95 (d, 1 H, J = 3.6 Hz), 7.15 (d, 1 H, J = 3.6 Hz), 7.19 (d, 1
H, J = 4.0 Hz), 7.92 (s, 1 H), 8.56 (d, 1 H, J = 4.0 Hz). 13C NMR
(CDCl3): δ [ppm] 14.2, 22.8, 25.8, 26.3, 29.4, 29.5, 29.6, 29.7, 29.75,
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by Robert Bosch (SEA) Pte. Ltd.
10040
dx.doi.org/10.1021/jo301281d | J. Org. Chem. 2012, 77, 10035−10041